User profiles for Michael Heneghan

Michael Heneghan

Institute of Liver Studies, King's College Hospital
Verified email at nhs.net
Cited by 17973

Liver disease in pregnancy

…, A James, A Quaglia, RH Westbrook, MA Heneghan - The Lancet, 2010 - thelancet.com
Severe liver disease in pregnancy is rare. Pregnancy-related liver disease is the most frequent
cause of liver dysfunction in pregnancy and provides a real threat to fetal and maternal …

Autoimmune hepatitis

MA Heneghan, AD Yeoman, S Verma, AD Smith… - The Lancet, 2013 - thelancet.com
Autoimmune hepatitis is a disease of the hepatic parenchyma that can present in acute or
chronic forms. In common with many autoimmune diseases, autoimmune hepatitis is …

Twin studies in autoimmune disease: genetics, gender and environment

…, EI Rigopoulou, MG Mytilinaiou, MA Heneghan… - Journal of …, 2012 - Elsevier
Twin studies are powerful tools to discriminate whether a complex disease is due to genetic
or environmental factors. High concordance rates among monozygotic (MZ) twins support …

Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial

…, SR Zeldenrust, T Yamashita, MA Heneghan… - Jama, 2013 - jamanetwork.com
Importance Familial amyloid polyneuropathy, a lethal genetic disease caused by aggregation
of variant transthyretin, induces progressive peripheral nerve deficits and disability. …

Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis

…, HJ Cordell, CS Franklin, SY Shin, MA Heneghan… - Nature …, 2011 - nature.com
In addition to the HLA locus, six genetic risk factors for primary biliary cirrhosis (PBC) have
been identified in recent genome-wide association studies (GWAS). To identify additional loci, …

Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful

…, A Bolton, R Goldberg, L Gordon, M Heneghan… - JAmA, 1995 - jamanetwork.com
Objective. —To assess the safety and efficacy of optic nerve decompression surgery
compared with careful follow-up alone in patients with nonarteritic anterior ischemic optic …

Efficacy and safety of elafibranor in primary biliary cholangitis

…, SM Francque, MA Heneghan… - … England Journal of …, 2024 - Mass Medical Soc
Background Primary biliary cholangitis is a rare, chronic cholestatic liver disease characterized
by the destruction of interlobular bile ducts, leading to cholestasis and liver fibrosis. …

Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid

…, G Pells, MF Dawwas, JL Newton, MA Heneghan… - Gastroenterology, 2013 - Elsevier
BACKGROUND, & AIMS: Studies of primary biliary cirrhosis (PBC) phenotypes largely have
been performed using small and selected populations. Study size has precluded …

[PDF][PDF] The UK‐PBC risk scores: derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis

…, A Bathgate, AK Burroughs, MA Heneghan… - …, 2016 - Wiley Online Library
The biochemical response to ursodeoxycholic acid (UDCA)—so‐called “treatment response”—strongly
predicts long‐term outcome in primary biliary cholangitis (PBC). Several long‐…

Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis

…, HJ Cordell, SJ Ducker, DB Day, MA Heneghan… - Nature …, 2012 - nature.com
We genotyped 2,861 cases of primary biliary cirrhosis (PBC) from the UK PBC Consortium
and 8,514 UK population controls across 196,524 variants within 186 known autoimmune risk …